
2026年12月4-6日,欧洲肿瘤内科学会亚洲年会(ESMO Asia Congress 2026)即将于新加坡拉开帷幕。本届大会摘要标题现已在官网发布,
摘要号:156eP
研究名称(英文):Smoking promotes colorectal cancer risk mediated by type 2 diabetes: a Mendelian randomization study
研究名称(中文):2 型
讲者:Yu Zhou | 中国福州
摘要号:164P
研究名称(英文):Attention-enhanced digital pathology for MSI prediction in colorectal cancer
研究名称(中文):基于注意力增强数字病理技术预测结直肠癌微卫星不稳定状态
讲者:Yunxia Huang | 中国厦门
摘要号:165P
研究名称(英文):Preclinical and first-in-human evaluation of [68Ga]NODAGA-SNA009 for PET imaging of GPA33 expression in colorectal cancer
研究名称(中文):[⁶⁸Ga] NODAGA-SNA009 用于结直肠癌 GPA33 表达 PET 显像的临床前及首个人体评估
讲者:Dong Dai | 中国天津
摘要号:168P
研究名称(英文):NAMPT-driven NAD⁺ metabolism orchestrates a tumor stiffness–immune axis that mediates immunotherapy resistance in MSS colorectal cancer
研究名称(中文):NAMPT 调控的 NAD⁺代谢构建肿瘤硬度 - 免疫轴,介导微卫星稳定型结直肠癌免疫治疗耐药
讲者:Chenyang Ye丨中国杭州
摘要号:171P
研究名称(英文):Tissue-specific mapping of genetic susceptibility in colorectal cancer identifies epithelial and endothelial driver genes and validates the association between WDR74 and oxaliplatin chemoresistance
研究名称(中文):结直肠癌遗传易感性的组织特异性图谱:鉴定上皮及内皮驱动基因并验证 WDR74 与
讲者:Tingyao Liu丨中国珠海
摘要号:178P
研究名称(英文):Neoadjuvant fruquintinib plus tislelizumab and mCapeOX for pMMR/MSS locally advanced rectal cancer: Safety lead-in results of a prospective, randomized, multicenter trial
研究名称(中文):
讲者:Xiaokang Lei丨中国北京
摘要号:180P
研究名称(英文):CT–MRI Multimodal Imaging-based Characterization of Indeterminate Pulmonary Nodules in Rectal Cancer
研究名称(中文):基于CT-MRI多模态影像评估直肠癌患者性质未定
讲者:Liao Yijun丨中国广州
摘要号:183P
研究名称(英文):Time-Varying Relapse Risk and Surveillance Intensity After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases
研究名称(中文):初始不可切除结直肠癌肝转移转化肝切除术后复发风险的时变特征与随访强度探讨
讲者:Yijiao Chen | 中国上海
摘要号:184P
研究名称(英文):Peritumoral multimodal radiomics predicts CRLM recurrence
研究名称(中文):瘤周多模态影像组学预测结直肠癌肝转移复发
讲者:Yanzong Lin丨中国厦门
摘要号:186P
研究名称(英文):Postoperative intraperitoneal raltitrexed after cytoreductive surgery for colorectal peritoneal metastases: a single-centre, open-label, phase 1b dose-escalation study
研究名称(中文):肿瘤减灭术后腹腔灌注
讲者:Guoxiang Cai丨中国上海
摘要号:188P
研究名称(英文):Metastasectomy, hepatic resection margin status, and survival with first-line panitumumab or cetuximab in RAS wild-type metastatic colorectal cancer: a Taiwanese multicenter cohort
研究名称(中文):RAS 野生型转移性结直肠癌一线帕尼单抗或
讲者:Pei Hung Chang | 中国台湾
摘要号:190P
研究名称(英文):Final analysis of CAPability-01: A phase Il trial of combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer
研究名称(中文):CAPability-01 研究最终分析:抗 PD-1 联合 HDAC 抑制剂及抗 VEGF 治疗 MSS/pMMR 结直肠癌的 Ⅱ 期研究
讲者:Yu-Kun Chen | 中国广州
摘要号:192P
研究名称(英文):Sintilimab plus bevacizumab and CapeOx as first-line treatment in RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer patients: Updated survival results and biomarker analyses of the BBCAPX-II study
研究名称(中文):
讲者:Ning Zhu | 中国杭州
摘要号:193eP
研究名称(英文):Precemtabart tocentecan (Precem-TcT) in Chinese patients with metastatic colorectal cancer (mCRC): results from the PROCEADE-CRC-02 study
研究名称(中文):Precemtabart tocentecan(Precem-TcT)用于中国转移性结直肠癌患者:PROCEADE-CRC-02 研究结果
讲者:Yanhong Deng | 中国广州
摘要号:194P
研究名称(英文):UGT1A1 genotype-guided Irinotecan liposome combined with 5-FU/LV+ bevacizumab as first-line therapy in metastatic colorectal cancer:multicenter, phase II clinical study
研究名称(中文):基于 UGT1A1 基因型指导的
讲者:Yuwen Zhou|中国成都
摘要号:195P
研究名称(英文):BETTER Trial: The Efficacy and Safety of Bevacizumab Combined with Trifluridine/Tipiracil, Stereotactic Body Radiotherapy, and Tislelizumab in Patients with Microsatellite-Stable Metastatic Colorectal Cancer Receiving Third-Line Therapy
研究名称(中文):BETTER 研究:贝伐珠单抗联合
讲者:JQun Zhang丨中国南京
摘要号:197P
研究名称(英文):Antibiotic Exposure Prior to Radiotherapy and Survival Outcomes in Colorectal Cancer: A Propensity Score-Matched Real-World Analysis Using the TriNetX Global Network
研究名称(中文):结直肠癌放疗前抗生素暴露与生存结局:基于 TriNetX 全球数据库的倾向性评分匹配真实世界分析
讲者:Tisha Lazuana丨中国台湾
摘要号:198P
研究名称(英文):Propensity Score Matching Multicenter Study of Maintenance Strategies versus Drug-free Treatment Break After First-line Systemic Therapy for Metastatic Colorectal Cancer - The Retrospective TRACC Registry
研究名称(中文):转移性结直肠癌一线全身治疗后维持治疗对比停药间歇策略:倾向性评分匹配多中心研究 —— 回顾性 TRACC 登记库研究
讲者:Kin Tsun Lee丨中国香港
摘要号:201P
研究名称(英文):Fruquintinib Monotherapy Versus Fruquintinib Combined with Chemotherapy in Patients with Refractory Metastatic Colorectal Cancer: A Real-World Retrospective Cohort Study
研究名称(中文):呋喹替尼单药对比呋喹替尼联合化疗治疗难治性转移性结直肠癌:一项真实世界回顾性队列研究
讲者:Jen Pei Huang丨中国台湾
摘要号:218eP
研究名称(英文):Safety and Feasibility of Preserving the Left Colic Artery and Clearing No.253 Lymph Nodes via Caudal Triangular Region Dissection in LRRRC for Rectal Cancer
研究名称(中文):低位直肠癌尾侧三角区清扫保留左结肠动脉并清扫 253 组淋巴结的安全性与可行性
讲者:Pengxing Li丨中国南平
摘要号:224eP
研究名称(英文):Vitamin E plus fruquintinib and tislelizumab in refractory microsatellite-stable metastatic colorectal cancer: interim results of the phase II VENTIF study
研究名称(中文):
讲者:Dawei Li丨中国上海
摘要号:226eP
研究名称(英文):KBD166: A Novel Neurotensin Receptor 1 (NTSR1) Ligand for Solid Tumor Therapy
研究名称(中文):KBD166:一种靶向神经降压素受体 1(NTSR1)的新型配体,用于实体瘤治疗
讲者:Jing Zhang丨中国成都
摘要号:234eP
研究名称(英文):Trajectories and risk stratification of patient-reported affective toxicity during colorectal cancer chemotherapy: a real-world longitudinal study
研究名称(中文):结直肠癌化疗期间患者自评情感毒性的变化轨迹与风险分层:一项真实世界纵向研究
讲者:Yuming Zhang丨中国西安
摘要号:235eP
研究名称(英文):Oxaliplatin-associated affective toxicity in colorectal cancer is mediated by the IDO1-kynurenine-gut microbiota-ACC neuroimmune axis
研究名称(中文):IDO1-犬尿氨酸-肠道菌群-ACC神经免疫轴介导结直肠癌奥沙利铂相关情感毒性
讲者:Zhijun Mao丨中国西安
撰写:Aurora
审核:Aurora
排版:Aurora
执行:Aurora
